Agreement between NRDC and CCRAS

The National Research Development Corporation (NRDC), signed a Memorandum of Association (MoA) with Central Council for Research in Ayurvedic Sciences (CCRAS) on 03.03.2015 for licensing of the technologies developed at the research council to entrepreneurs /companies for commercial exploitation. The benefits that are likely to accrue from the MoA are the following: The Ayurvedic formulations and products

manufactured by the licensee companies are used by the common people for treatment/management of various diseases.

·                     The licensing of the technologies to companies is a source of revenue in terms of lump-sum fee and royalty, which is shared between NRDC and CCRAS.

NRDC has licensed an Anti-Diabetic Ayurvedic formulation for management of Diabetes, viz. ‘AYUSH-82’, developed by CCRAS and assigned to NRDC in February, 2016 to five companies / firms in India till date. The details of these during the last three years and the current year, State-wise and company-wise are as follows:

S. No.

Name of Company

Date of Signing of Agreement

    Financial Year 2016-17

           State - Uttarakhand

1.

M/s Chaturbhuj Pharmaceutical Co.

SIDCUL  Industrial Area, Haridwar

30-05-2016

            State  - Himachal Pradesh

2.

Altis Life Sciences, Baddi

03-07-2016

      Financial Year 2015-16

            State - Uttarakhand

3.

M/s LA Grande Herbs & Pharma Ltd.

SIDCUL  Industrial Area, Haridwar

31-03-2016

            State - Delhi

4.

M/s Kudos Laboratories India Ltd. New Delhi

16-03-2016

5.

M/s Dabur India Ltd,

Asaf Ali Road, New Delhi

18-02-2016

     Financial Year 2014-15

 NIL, as the technology was assigned to NRDC in Feb 2016

      Financial Year 2013-14

NIL, as the technology was assigned to NRDC in Feb 2016

This was stated by Union Minister for Science & Technology and Earth Sciences, Dr. Harsh Vardhan in a written reply to a Question in Lok Sabha on 27th July, 2016.